This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

ERx (Electronic Prescribing/e-Prescribing) Market By Hardware, Software, Services, End-users (Medical Group Practice & Hospitals), Products (Integrated & Standalone Systems) & Deployment (Licensed, Web-hosted & Cloud) - Global Forecasts To 2017

 

The healthcare industry is plagued by the issue of privacy and maintaining security of patient data. This has been a roadblock for the entry of any new technological solution in the healthcare industry which involves patient data or patient medical records. Moreover, the limited access for experts opinion and technically trained IT professionals is expected to negatively impact the market because there is lack of awareness among end users mainly prescribers, pharmacist and associated staff regarding the working and function of applications, best vendors available in the market, cost of software and long term service provision.

 

Key players in the market are Cerner Corporation (U.S.), Allscripts (U.S.), Quality Systems, Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.).

 

Scope of the Report

 

The scope of the report spans the electronic prescribing systems market which comprises:

 

Global e-Prescribing Systems Market

By Type

Stand-alone systems

Integrated systems

By Component

Hardware

Software

Services

By Delivery Mode

Licensed (on-premise)

Web-hosted

Cloud hosted

By Usage Mode

PC-based

Hand-held

By End-user

Hospitals

Office-based physicians

By Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)

 

Each section of the report offers market data for the various market segments and geographies. It also provides market trends with respect to drivers, restraints, and opportunities.

 

 

 

TABLE OF CONTENTS

 

1 INTRODUCTION 18

 

1.1 KEY TAKE-AWAYS 18

1.2 REPORT DESCRIPTION 18

1.3 MARKETS COVERED 19

1.4 STAKEHOLDERS 20

1.5 RESEARCH METHODOLOGY 20

1.5.1 MARKET SIZE 20

1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES 21

1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES 21

1.5.4 ASSUMPTIONS 21

 

2 EXECUTIVE SUMMARY 22

 

3 MARKET OVERVIEW 24

 

3.1 E-PRESCRIBING SYSTEM 25

3.1.1 E-PRESCRIBING PROCESS 26

2 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs